Physioneal 40 Glucose 2.27% 0.14 g (Magnesium Chloride SOLUTION) 0.14 G

Physioneal 40 Glucose 2.27% with Magnesium Chloride 0.14g is a specialized solution used in haemodialysis and intraperitoneal applications. This product supports electrolyte balance and fluid management, formulated for medical use.

Strength

0.14 G

Manufacturer / TM Owner

VANTIVE ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Physioneal 40 Glucose 2.27% with Magnesium Chloride 0.14g is primarily used in haemodialysis and intraperitoneal treatments. It helps maintain electrolyte levels and supports fluid balance in the body. This solution is designed for medical procedures requiring precise electrolyte management.

Side Effects

When used as directed, Physioneal 40 Glucose 2.27% with Magnesium Chloride 0.14g may help regulate fluid levels and support electrolyte balance. Users may experience improved comfort and stability during dialysis or intraperitoneal treatments.

Precautions & Warnings

Handle Physioneal 40 Glucose 2.27% with Magnesium Chloride 0.14g with care, following medical guidelines. Ensure proper storage and use as directed by healthcare professionals. Always check for any signs of contamination before use.

Avoid Interactions

Physioneal 40 Glucose 2.27% with Magnesium Chloride 0.14g may interact with other medications or supplements. Consult a healthcare provider before combining with other treatments. Be aware of potential interactions with alcohol or other substances.

Frequently Asked Questions

It is used in haemodialysis and intraperitoneal treatments to support electrolyte balance and fluid management.

Store according to the manufacturer's instructions, typically in a cool, dry place away from direct sunlight.

Consult a healthcare provider before combining with other treatments to avoid potential interactions.

Users may experience improved fluid balance and electrolyte regulation during dialysis or intraperitoneal treatments.

Safety depends on individual health conditions; always follow medical advice and guidelines.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.